A personalized approach to the management of VWD
Research output: Contribution to journal › Article
The goal of treating Von Willebrand Disease (VWD) is to replace deficient or dysfunctional Von Willebrand Factor (VWF) protein. However, the choice of treatment has to be considered carefully in view of patient factors and the unique properties of replacement products. Tailoring a treatment plan to an individual patient's bleeding challenge is an intricate process. This review describes personalization of treatment selection for desmopressin (DDAVP), VWF replacement concentrates, including the newly available recombinant VWF (rVWF) and prophylaxis as a treatment approach in VWD.
|Research areas and keywords||
Subject classification (UKÄ) – MANDATORY
|Journal||Transfusion and Apheresis Science|
|Publication status||E-pub ahead of print - 2019 Aug 7|